Loading…
Arsenic toxicity manifesting as profuse watery diarrhea during induction therapy for acute promyelocytic leukemia
Arsenic trioxide (ATO) is generally well tolerated for treatment of APL. We present a patient with severe watery diarrhea and pancreatitis thought to be due to ATO toxicity in the setting of obesity and acute kidney injury. Future studies evaluating ATO levels in patients experiencing toxicities may...
Saved in:
Published in: | Clinical case reports 2021-05, Vol.9 (5), p.e04115-n/a |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c5715-86c68147aeb1cb32705887215b525e8378d26234608bf4851c3c4e231580f1953 |
---|---|
cites | cdi_FETCH-LOGICAL-c5715-86c68147aeb1cb32705887215b525e8378d26234608bf4851c3c4e231580f1953 |
container_end_page | n/a |
container_issue | 5 |
container_start_page | e04115 |
container_title | Clinical case reports |
container_volume | 9 |
creator | Ott, Ashley Venkataraman, Vinayak Badran, Yousef R. Goldman, Rose Spasic, Smiljana Vyas, Darshali A. Amrein, Philip McAfee, Steven Brunner, Andrew Fathi, Amir T. Narayan, Rupa |
description | Arsenic trioxide (ATO) is generally well tolerated for treatment of APL. We present a patient with severe watery diarrhea and pancreatitis thought to be due to ATO toxicity in the setting of obesity and acute kidney injury. Future studies evaluating ATO levels in patients experiencing toxicities may help guide dose modifications.
Arsenic trioxide (ATO) is generally well tolerated for treatment of APL. We present a patient with severe watery diarrhea and pancreatitis thought to be due to ATO toxicity in the setting of obesity and acute kidney injury. Future studies evaluating ATO levels in patients experiencing toxicities may help guide dose modifications. |
doi_str_mv | 10.1002/ccr3.4115 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_494d082f35284bb09e1061365acbe062</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_494d082f35284bb09e1061365acbe062</doaj_id><sourcerecordid>2536756538</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5715-86c68147aeb1cb32705887215b525e8378d26234608bf4851c3c4e231580f1953</originalsourceid><addsrcrecordid>eNp9kk1r3DAQhkVpacI2h_6BIuiph01GHyNrL4Ww9CMQKJT2LGR5vKut19rIdlL_-9rZNCSH9iQhPXpmRryMvRVwLgDkRQhZnWsh8AU7lYCwhBXol0_2J-ys63YAIKCQKOA1O1EapBGIp-zmMnfUxsD79DuG2I9879tYU9fHdsN9xw851UNH_M73lEdeRZ_zljyvhjwTsa2G0MfU8n5L2R9GXqfMfRh6mp_uR2pSGPupQEPDL9pH_4a9qn3T0dnDumA_P3_6sf66vP725Wp9eb0MWAhcWhOMFbrwVIpQKlkAWltIgSVKJKsKW0kjlTZgy1pbFEEFTVIJtFCLFaoFuzp6q-R37pDj3ufRJR_d_UHKG-fz1FhDTq90BVbWCqXVZQkrEmCEMuhDSTBVWbCPR9dhKPdUBWr77Jtn0uc3bdy6Tbp1VkgphZ0E7x8EOd0M0--6XRpyO83vJOI0lpG6-D-lTIEG1ez6cKRCTl2XqX7sQ4CbI-HmSLg5EhP77mnjj-TfAEzAxRG4iw2N_za59fq7ulf-AQ1_v2U</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2536756538</pqid></control><display><type>article</type><title>Arsenic toxicity manifesting as profuse watery diarrhea during induction therapy for acute promyelocytic leukemia</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database</source><source>Coronavirus Research Database</source><source>Wiley-Blackwell Open Access Titles(OpenAccess)</source><creator>Ott, Ashley ; Venkataraman, Vinayak ; Badran, Yousef R. ; Goldman, Rose ; Spasic, Smiljana ; Vyas, Darshali A. ; Amrein, Philip ; McAfee, Steven ; Brunner, Andrew ; Fathi, Amir T. ; Narayan, Rupa</creator><creatorcontrib>Ott, Ashley ; Venkataraman, Vinayak ; Badran, Yousef R. ; Goldman, Rose ; Spasic, Smiljana ; Vyas, Darshali A. ; Amrein, Philip ; McAfee, Steven ; Brunner, Andrew ; Fathi, Amir T. ; Narayan, Rupa</creatorcontrib><description>Arsenic trioxide (ATO) is generally well tolerated for treatment of APL. We present a patient with severe watery diarrhea and pancreatitis thought to be due to ATO toxicity in the setting of obesity and acute kidney injury. Future studies evaluating ATO levels in patients experiencing toxicities may help guide dose modifications.
Arsenic trioxide (ATO) is generally well tolerated for treatment of APL. We present a patient with severe watery diarrhea and pancreatitis thought to be due to ATO toxicity in the setting of obesity and acute kidney injury. Future studies evaluating ATO levels in patients experiencing toxicities may help guide dose modifications.</description><identifier>ISSN: 2050-0904</identifier><identifier>EISSN: 2050-0904</identifier><identifier>DOI: 10.1002/ccr3.4115</identifier><identifier>PMID: 34026155</identifier><language>eng</language><publisher>England: John Wiley & Sons, Inc</publisher><subject>Abdomen ; Antibiotics ; APL ; APML ; Arsenic ; Blood ; Cardiac arrhythmia ; Case Report ; Case Reports ; Creatinine ; Diarrhea ; Drug dosages ; Induction therapy ; Leukemia ; Metabolites ; Nausea ; obesity ; Pancreatitis ; Patients ; Peripheral neuropathy ; Poisoning ; renal insufficiency ; Severe acute respiratory syndrome coronavirus 2 ; Toxicity ; Urine ; Vomiting</subject><ispartof>Clinical case reports, 2021-05, Vol.9 (5), p.e04115-n/a</ispartof><rights>2021 The Authors. published by John Wiley & Sons Ltd.</rights><rights>2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.</rights><rights>2021. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5715-86c68147aeb1cb32705887215b525e8378d26234608bf4851c3c4e231580f1953</citedby><cites>FETCH-LOGICAL-c5715-86c68147aeb1cb32705887215b525e8378d26234608bf4851c3c4e231580f1953</cites><orcidid>0000-0002-4675-6503</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2557216247/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2557216247?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,11562,25753,27924,27925,37012,38516,43895,44590,46052,46476,53791,53793,74412,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34026155$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ott, Ashley</creatorcontrib><creatorcontrib>Venkataraman, Vinayak</creatorcontrib><creatorcontrib>Badran, Yousef R.</creatorcontrib><creatorcontrib>Goldman, Rose</creatorcontrib><creatorcontrib>Spasic, Smiljana</creatorcontrib><creatorcontrib>Vyas, Darshali A.</creatorcontrib><creatorcontrib>Amrein, Philip</creatorcontrib><creatorcontrib>McAfee, Steven</creatorcontrib><creatorcontrib>Brunner, Andrew</creatorcontrib><creatorcontrib>Fathi, Amir T.</creatorcontrib><creatorcontrib>Narayan, Rupa</creatorcontrib><title>Arsenic toxicity manifesting as profuse watery diarrhea during induction therapy for acute promyelocytic leukemia</title><title>Clinical case reports</title><addtitle>Clin Case Rep</addtitle><description>Arsenic trioxide (ATO) is generally well tolerated for treatment of APL. We present a patient with severe watery diarrhea and pancreatitis thought to be due to ATO toxicity in the setting of obesity and acute kidney injury. Future studies evaluating ATO levels in patients experiencing toxicities may help guide dose modifications.
Arsenic trioxide (ATO) is generally well tolerated for treatment of APL. We present a patient with severe watery diarrhea and pancreatitis thought to be due to ATO toxicity in the setting of obesity and acute kidney injury. Future studies evaluating ATO levels in patients experiencing toxicities may help guide dose modifications.</description><subject>Abdomen</subject><subject>Antibiotics</subject><subject>APL</subject><subject>APML</subject><subject>Arsenic</subject><subject>Blood</subject><subject>Cardiac arrhythmia</subject><subject>Case Report</subject><subject>Case Reports</subject><subject>Creatinine</subject><subject>Diarrhea</subject><subject>Drug dosages</subject><subject>Induction therapy</subject><subject>Leukemia</subject><subject>Metabolites</subject><subject>Nausea</subject><subject>obesity</subject><subject>Pancreatitis</subject><subject>Patients</subject><subject>Peripheral neuropathy</subject><subject>Poisoning</subject><subject>renal insufficiency</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Toxicity</subject><subject>Urine</subject><subject>Vomiting</subject><issn>2050-0904</issn><issn>2050-0904</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9kk1r3DAQhkVpacI2h_6BIuiph01GHyNrL4Ww9CMQKJT2LGR5vKut19rIdlL_-9rZNCSH9iQhPXpmRryMvRVwLgDkRQhZnWsh8AU7lYCwhBXol0_2J-ys63YAIKCQKOA1O1EapBGIp-zmMnfUxsD79DuG2I9879tYU9fHdsN9xw851UNH_M73lEdeRZ_zljyvhjwTsa2G0MfU8n5L2R9GXqfMfRh6mp_uR2pSGPupQEPDL9pH_4a9qn3T0dnDumA_P3_6sf66vP725Wp9eb0MWAhcWhOMFbrwVIpQKlkAWltIgSVKJKsKW0kjlTZgy1pbFEEFTVIJtFCLFaoFuzp6q-R37pDj3ufRJR_d_UHKG-fz1FhDTq90BVbWCqXVZQkrEmCEMuhDSTBVWbCPR9dhKPdUBWr77Jtn0uc3bdy6Tbp1VkgphZ0E7x8EOd0M0--6XRpyO83vJOI0lpG6-D-lTIEG1ez6cKRCTl2XqX7sQ4CbI-HmSLg5EhP77mnjj-TfAEzAxRG4iw2N_za59fq7ulf-AQ1_v2U</recordid><startdate>202105</startdate><enddate>202105</enddate><creator>Ott, Ashley</creator><creator>Venkataraman, Vinayak</creator><creator>Badran, Yousef R.</creator><creator>Goldman, Rose</creator><creator>Spasic, Smiljana</creator><creator>Vyas, Darshali A.</creator><creator>Amrein, Philip</creator><creator>McAfee, Steven</creator><creator>Brunner, Andrew</creator><creator>Fathi, Amir T.</creator><creator>Narayan, Rupa</creator><general>John Wiley & Sons, Inc</general><general>John Wiley and Sons Inc</general><general>Wiley</general><scope>24P</scope><scope>WIN</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-4675-6503</orcidid></search><sort><creationdate>202105</creationdate><title>Arsenic toxicity manifesting as profuse watery diarrhea during induction therapy for acute promyelocytic leukemia</title><author>Ott, Ashley ; Venkataraman, Vinayak ; Badran, Yousef R. ; Goldman, Rose ; Spasic, Smiljana ; Vyas, Darshali A. ; Amrein, Philip ; McAfee, Steven ; Brunner, Andrew ; Fathi, Amir T. ; Narayan, Rupa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5715-86c68147aeb1cb32705887215b525e8378d26234608bf4851c3c4e231580f1953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Abdomen</topic><topic>Antibiotics</topic><topic>APL</topic><topic>APML</topic><topic>Arsenic</topic><topic>Blood</topic><topic>Cardiac arrhythmia</topic><topic>Case Report</topic><topic>Case Reports</topic><topic>Creatinine</topic><topic>Diarrhea</topic><topic>Drug dosages</topic><topic>Induction therapy</topic><topic>Leukemia</topic><topic>Metabolites</topic><topic>Nausea</topic><topic>obesity</topic><topic>Pancreatitis</topic><topic>Patients</topic><topic>Peripheral neuropathy</topic><topic>Poisoning</topic><topic>renal insufficiency</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Toxicity</topic><topic>Urine</topic><topic>Vomiting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ott, Ashley</creatorcontrib><creatorcontrib>Venkataraman, Vinayak</creatorcontrib><creatorcontrib>Badran, Yousef R.</creatorcontrib><creatorcontrib>Goldman, Rose</creatorcontrib><creatorcontrib>Spasic, Smiljana</creatorcontrib><creatorcontrib>Vyas, Darshali A.</creatorcontrib><creatorcontrib>Amrein, Philip</creatorcontrib><creatorcontrib>McAfee, Steven</creatorcontrib><creatorcontrib>Brunner, Andrew</creatorcontrib><creatorcontrib>Fathi, Amir T.</creatorcontrib><creatorcontrib>Narayan, Rupa</creatorcontrib><collection>Wiley-Blackwell Open Access Titles(OpenAccess)</collection><collection>Wiley-Blackwell Open Access Backfiles (Open Access)</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Complete (ProQuest Database)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Clinical case reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ott, Ashley</au><au>Venkataraman, Vinayak</au><au>Badran, Yousef R.</au><au>Goldman, Rose</au><au>Spasic, Smiljana</au><au>Vyas, Darshali A.</au><au>Amrein, Philip</au><au>McAfee, Steven</au><au>Brunner, Andrew</au><au>Fathi, Amir T.</au><au>Narayan, Rupa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Arsenic toxicity manifesting as profuse watery diarrhea during induction therapy for acute promyelocytic leukemia</atitle><jtitle>Clinical case reports</jtitle><addtitle>Clin Case Rep</addtitle><date>2021-05</date><risdate>2021</risdate><volume>9</volume><issue>5</issue><spage>e04115</spage><epage>n/a</epage><pages>e04115-n/a</pages><issn>2050-0904</issn><eissn>2050-0904</eissn><abstract>Arsenic trioxide (ATO) is generally well tolerated for treatment of APL. We present a patient with severe watery diarrhea and pancreatitis thought to be due to ATO toxicity in the setting of obesity and acute kidney injury. Future studies evaluating ATO levels in patients experiencing toxicities may help guide dose modifications.
Arsenic trioxide (ATO) is generally well tolerated for treatment of APL. We present a patient with severe watery diarrhea and pancreatitis thought to be due to ATO toxicity in the setting of obesity and acute kidney injury. Future studies evaluating ATO levels in patients experiencing toxicities may help guide dose modifications.</abstract><cop>England</cop><pub>John Wiley & Sons, Inc</pub><pmid>34026155</pmid><doi>10.1002/ccr3.4115</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0002-4675-6503</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2050-0904 |
ispartof | Clinical case reports, 2021-05, Vol.9 (5), p.e04115-n/a |
issn | 2050-0904 2050-0904 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_494d082f35284bb09e1061365acbe062 |
source | Open Access: PubMed Central; Publicly Available Content Database; Coronavirus Research Database; Wiley-Blackwell Open Access Titles(OpenAccess) |
subjects | Abdomen Antibiotics APL APML Arsenic Blood Cardiac arrhythmia Case Report Case Reports Creatinine Diarrhea Drug dosages Induction therapy Leukemia Metabolites Nausea obesity Pancreatitis Patients Peripheral neuropathy Poisoning renal insufficiency Severe acute respiratory syndrome coronavirus 2 Toxicity Urine Vomiting |
title | Arsenic toxicity manifesting as profuse watery diarrhea during induction therapy for acute promyelocytic leukemia |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T10%3A24%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Arsenic%20toxicity%20manifesting%20as%20profuse%20watery%20diarrhea%20during%20induction%20therapy%20for%20acute%20promyelocytic%20leukemia&rft.jtitle=Clinical%20case%20reports&rft.au=Ott,%20Ashley&rft.date=2021-05&rft.volume=9&rft.issue=5&rft.spage=e04115&rft.epage=n/a&rft.pages=e04115-n/a&rft.issn=2050-0904&rft.eissn=2050-0904&rft_id=info:doi/10.1002/ccr3.4115&rft_dat=%3Cproquest_doaj_%3E2536756538%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5715-86c68147aeb1cb32705887215b525e8378d26234608bf4851c3c4e231580f1953%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2536756538&rft_id=info:pmid/34026155&rfr_iscdi=true |